Neurogene Inc. (NGNE) stock
NGNENasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 7/30
$23.10−0.20 (-0.86%)
Close on Nov 17, 2026Market cap $462.26MP/E –Yield –
Neurogene ebitda
EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.
Neurogene's ebitda for the twelve months ending Jun 30, 2026 was -$118.11M. For fiscal 2025 it was -$100.29M. The highest annual figure on record is -$32.34M in fiscal 2018.
Annual ebitda
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$100.29M | – |
| FY2024 | Dec 31, 2024 | -$79.41M | – |
| FY2023 | Dec 31, 2023 | -$52.32M | – |
| FY2022 | Dec 31, 2022 | -$53.32M | – |
| FY2021 | Dec 31, 2021 | -$59.39M | – |
| FY2020 | Dec 31, 2020 | -$32.94M | – |
| FY2019 | Dec 31, 2019 | -$70.62M | – |
| FY2018 | Dec 31, 2018 | -$32.34M | – |
| FY2017 | Dec 31, 2017 | -$50.76M | – |
Quarterly ebitda
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$35.86M | – |
| Q1 FY2026 | Mar 31, 2026 | -$32.50M | – |
| Q4 FY2025 | Dec 31, 2025 | -$26.75M | – |
| Q3 FY2025 | Sep 30, 2025 | -$23.00M | – |
| Q2 FY2025 | Jun 30, 2025 | -$25.28M | – |
| Q1 FY2025 | Mar 31, 2025 | -$25.17M | – |
| Q4 FY2024 | Dec 31, 2024 | -$20.73M | – |
| Q3 FY2024 | Sep 30, 2024 | -$21.38M | – |
| Q2 FY2024 | Jun 30, 2024 | -$19.33M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.97M | – |
| Q4 FY2023 | Dec 31, 2023 | -$13.92M | – |
| Q3 FY2023 | Sep 30, 2023 | -$14.42M | – |
| Q2 FY2023 | Jun 30, 2023 | -$11.80M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.22M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.67M | – |
| Q3 FY2022 | Sep 30, 2022 | -$13.29M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.41M | – |
| Q1 FY2022 | Mar 31, 2022 | -$14.95M | – |
| Q4 FY2021 | Dec 31, 2021 | -$14.78M | – |
| Q3 FY2021 | Sep 30, 2021 | -$15.10M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.81M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.70M | – |
| Q4 FY2020 | Dec 31, 2020 | -$12.43M | – |
| Q3 FY2020 | Sep 30, 2020 | -$2.06M | – |
| Q2 FY2020 | Jun 30, 2020 | -$9.55M | – |
| Q1 FY2020 | Mar 31, 2020 | -$8.90M | – |
| Q4 FY2019 | Dec 31, 2019 | -$8.20M | – |
| Q3 FY2019 | Sep 30, 2019 | -$59.42M | – |
| Q2 FY2019 | Jun 30, 2019 | -$387.00K | – |
See a number that looks wrong?